• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Varian

Varian

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Proton Therapy Market in Switzerland - Reimbursement Policy, Patients Treated at Proton Facility & Forecast - Research and Markets

    Proton Therapy Market in Switzerland - Reimbursement Policy, Patients Treated at Proton Facility & Forecast - Research and Markets

  2. South Korea Proton Therapy Market - Expected to Almost Triple by 2021 from its Current Market Size in 2016 - Research and Markets

    South Korea Proton Therapy Market - Expected to Almost Triple by 2021 from its Current Market Size in 2016 - Research and Markets

  3. Energy Based Ablation Devices - Global Strategic Business Report 2017 - Research and Markets

    Energy Based Ablation Devices - Global Strategic Business Report 2017 - Research and Markets

  4. Research Roundup: Foreign Diversification, Social Comparisons and Consumer Identity

    Varian Medical's VAR third-quarter fiscal 2006 results fall right in line with the seasonal patterns we expected from our current near-term modeling assumptions. The oncology group notched 14% growth, and customer demand continues to reflect a shift toward Varian's next-generation IGRT technology, ...

  5. Greece’s Darkest Hour Before Its Dawn

    Varian Medical Systems' VAR third-quarter results were in line with our expectations, and we are leaving our fair value estimate unchanged. Overall, revenue increased 7%, and net orders rose 13%, bringing the company's backlog at quarter-end to $1.6 billion. Revenue for the oncology system segment ...

  6. Health Care: A Few Stocks Still Offer Upside

    Despite the sector looking slightly overvalued, we still see stocks with attractive valuations across the different industries.

  7. Health Care: 3 Picks in a More Expensive Sector

    Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.

  8. A Deeper Look at the Applied Materials-Tokyo Electron Merger

    The combination makes plenty of sense and should better position the firm for the future.

  9. Health Care: A Strong Run, but Some Stocks Still Look Undervalued

    While the sector looks slightly overvalued overall, we still see several stocks that offer attractive valuations across the different industries.

12

©2017 Morningstar Advisor. All right reserved.